In heart failure (HF), abnormal myocyte Ca 2+ handling has been implicated in cardiac arrhythmias and contractile dysfunction. In the present study, we investigated the relationships between Ca 2+ handling, reduced myocyte contractility, and enhanced arrhythmogenesis during HF progression in a canine model of non-ischaemic HF. oscillated essentially independent of electrical pacing. The increased propensity for the generation of SCWs in HF myocytes was attributable to reduced ability of the RyR2 channels to become refractory following Ca 2+ release.
in isolated ventricular myocytes at different stages of HF. The progression of HF was associated with an early and continuous increase in ryanodine receptor (RyR2)-mediated SR Ca 2+ leak. The increase in RyR2 activity was paralleled by an increase in the frequency of diastolic spontaneous Ca 2+ waves (SCWs) in HF myocytes under conditions of b-adrenergic stimulation. In addition to causing arrhythmogenic-delayed afterdepolarizations, SCWs decreased the amplitude of subsequent electrically evoked Ca 2+ transients by depleting SR Ca 2+ . At late stages of HF, Ca 2+ release oscillated essentially independent of electrical pacing. The increased propensity for the generation of SCWs in HF myocytes was attributable to reduced ability of the RyR2 channels to become refractory following Ca 2+ release.
The progressive alterations in RyR2 function and Ca 2+ cycling in HF myocytes were associated with sequential modifications of RyR2 by CaMKII-dependent phosphorylation and thiol oxidation.
Conclusion
These findings suggest that destabilized RyR2 activity due to excessive CaMKII phopshorylation and oxidation resulting in impaired post-release refractoriness is a common mechanism involved in arrhythmogenesis and contractile dysfunction in the failing heart.
Introduction
Systolic heart failure (HF) is an increasingly common and often lethal disease that occurs when the cardiac muscle is too weak to maintain a sufficient cardiac output. Patients with HF typically die either due to progressive failure of cardiac mechanical function (pump failure) or ventricular arrhythmias. 1 Multiple mechanisms, including remodelling of cellular ionic currents, alterations in gap junctions, and changes in the contractile apparatus, have been implicated in the pathophysiology of HF. 2, 3 In addition, abnormal myocyte Ca 2+ handling is increasingly recognized as an important factor in the development of both ventricular arrhythmias and contractile dysfunction in the failing heart. 4 -7 However, the specific mechanisms by which alterations in Ca 2+ cycling lead to these two different clinical manifestations of HF are poorly defined. Arrhythmogenesis in the failing heart has been associated with excessive, spontaneous sarcoplasmic reticulum (SR) Ca 2+ and delayed afterdepolarizations (DADs). 4, 5, 8, 9 The enhanced predisposition of myocytes isolated from failing hearts to SCWs has been ascribed to elevated SR Ca 2+ load secondary to the stimulation of SR Ca 2+ ATPase (SERCA) by the increased levels of circulating catecholamines combined with enhanced b 2 -adrenergic responsiveness in HF. 10 Additionally, up-regulation of the sodium/calcium exchanger (NCX), which would permit a more effective translation of cytosolic Ca 2+ elevations into DADs, has been suggested to contribute to the arrhythmogenic propensity during HF. 4, 11 In contrast, the weakened mechanical performance of the failing heart has been linked to reduced SR Ca 2+ release and weakened contractility of cardiac myocytes. 12 Increased leak of Ca 2+ from the SR (diastolic leak) is considered to be an important factor contributing to contractile dysfunction in HF secondary to reduced SR Ca 2+ content. 13 -16 Post-translational modifications of the cardiac ryanodine receptor (RyR2) either through phosphorylation by PKA 14 or
CaMKII, 16 or oxidation of reactive thiols, 17 
Methods
An expanded methods section can be found in the Supplementary material online.
Canine model of non-ischaemic HF
Ventricular dysfunction was induced by right ventricular (RV) tachypacing (TP), as described previously. 17 Briefly, adult hound dogs (25) (26) (27) (28) 
, where K d was 400 mM. 18 
Phosphorylation and oxidation of RyRs
Phosphorylation of RyRs at Ser-2808 and Ser-2814 were probed with antibodies kindly provided by Dr A.R. Marks (Columbia University, NY, USA) using standard procedures. 17 Reactive oxygen species (ROS) production
was measured with the fluorescent indicator 5-(and-6) chloromethyl-2 ′ ,7 ′ -dichlorodihydrofluoroscein diacetate (DCFDA). 17 After subtraction of background fluorescence, the signal was normalized to maximum fluorescence achieved by the application of 10 mM H 2 O 2 . The content of free thiols in RyRs was determined with the monobromobimane (mBB) fluorescence method. 17 mBB fluorescence was normalized to RyR2 amount determined using Coomassie Blue staining of the gels run in parallel.
Data analysis
Results are presented as mean + SEM. Statistical significance was evaluated either by Student's t-test or by one-way ANOVA. A P-value of ,0.05 was considered significant. were not altered in the 1 month heart failure (MHF) group but were significantly decreased in the 4 MHF when compared with controls ( Figure 1A and B; Ca 2+ handling during heart failure progression
SCWs contribute to both arrhythmogenesis and contractile dysfunction in HF
The arrhythmogenic potential at early and late stages of HF (1 and +16 MHF) was examined by measuring SCWs and DADs in myocytes paced in the presence of the b-adrenergic agonist, isoproterenol (ISO), as catecholamines are known to be increased in this model of HF. 19 An increase in the rate of occurrence of diastolic SCWs and DADs was observed at 1 MHF which tended to increase further at 16+ MHF ( Figure 3A and B) . Notably, the increase in the frequency of diastolic SCWs in ISO-stimulated HF myocytes was associated with a significant decrease in the amplitude of the systolic Ca 2+ transient as early as 1 MHF when compared with control cells ( Figure 3C ). Figure 3D , the amplitude of the systolic, AP-induced Ca transients that were not preceded by a SCW. The disrupting effect of irregular Ca 2+ release on myocyte Ca 2+ cycling and shortening was even more pronounced in myocytes at late stages of HF, in which cellular shortening often became effectively decoupled from pacing-induced electrical activity. An example of such severely disrupted myocyte Ca 2+ cycling and rhythmic shortening in advanced HF is shown in Figure 3E . handling due to HF-dependent changes in AP 20 were avoided by using a uniform AP clamp protocol with a 'typical' AP from a control cell as the voltage command. As shown in Figure 4A and Figure 5D ). Moreover, our data indicated that the attainment of a critical 'threshold' [Ca 2+ ] SR level was not sufficient to initiate the generation of SCWs. Indeed, the point at which Figure 5F ), suggesting that the intrinsic ability of the Ca 2+ release mechanism to remain refractory following SR Ca 2+ release is impaired, leading to the enhanced generation of SCWs.
Enhanced

Abnormal RyR2 function in HF involves both phosphorylative and redox modifications
Myocyte ROS production measured with DCFDA was not significantly altered at 1 MHF ( Figure 6A and B) . However, a progressive increase in ROS generation was detected at later stages of HF (at 4 and 16+ MHF). These changes in ROS production were paralleled by a similar increase in oxidation of RyR2s as determined by the mBB fluorescence method ( Figure 6C and D) . RyR2 phosphorylation at the putative PKA-and CaMKII-dependent sites 2808 and 2814, respectively, was assessed using phospho-specific antibodies. RyR2 phosphorylation at Ser-2814 increased approximately four-fold at 1 MHF with respect to control, and this effect was maintained at 16+ MHF ( Figure 6E and F ) . In contrast, we observed no significant changes in RyR2 phosphorylation at Ser-2808 in either 1 or 16+ MHF group. Therefore, HF duration was associated with specific time-dependent post-translational modifications of RyR2s, i.e. early and sustained increases in RyR2 phosphorylation at Ser-2814 followed by oxidative modification of thiols. A critical role for CaMKII activity in arrhythmogenesis at the early stages of HF progression was confirmed in experiments in which pharmacological inhibition of the kinase with KN-93 abolished diastolic Ca 2+ waves in field-stimulated HF myocytes at 1 MHF but not at 16 MHF ( Figure 6G -J ) . In addition, the inclusion of CaMKII inhibitory peptide in the pipette solution significantly inhibited the frequency of SCW in 1 MHF patch-clamped myocytes (data not shown).
Discussion
Early enhancement of SR Ca 21 leak and sustained EC coupling functional stability during HF progression
Elevated RyR2-mediated SR Ca 2+ leak is an important feature of myocytes from failing hearts at advanced stages of disease in both human and animal models, 13 -16 which is thought to contribute to the pathophysiology of HF either directly (by weakening contractility through depletion of the SR Ca 2+ stores and slowing relaxation via prolongation of the Ca 2+ transient) 13 or indirectly (by causing Ca 2+ -dependent pathological remodelling and cell death). 24 However, understanding the role of SR Ca 2+ leak as a causal factor in HF has been limited by the lack of evidence as to whether alterations in leak precede, parallel, or follow the development and progression of HF. In the present study, we found that enhanced diastolic SR Ca 2+ leak ( Figure 2) 
Arrhythmogenesis and contractile impairment are intrinsically linked
Increased RyR2 activity has been shown to lead to arrhythmogenesis due to SCWs and DADs, particularly, when combined with b-adrenergic stimulation. 8, 21 Accordingly, the increase in Ca were preceded with SCW in the diastolic phase were normalized to those that did not display SCW during the preceding diastolic interval. Data were recorded in HF myocytes (n ¼ 5 -9) as shown in (A). *P , 0.05.
spark frequency was paralleled with an increase in propensity to Ca 2+ waves and DADs in myocytes exposed to ISO at different stages of HF ( Figure 3) . Of note, the observed up-regulation of NCX would also be expected to contribute to increased arrhythmogenic propensity from early stages of HF by promoting DADs and their triggering extrasystolic APs. 4 Besides leading to arrhyth- by SCWs in the preceding diastolic period ( Figure 4D) . SCW-dependent inhibition of systolic Ca 2+ release was especially pronounced in myocytes at late stages of HF ( Figure 3E) deactivation. Additionally, phosphorylation of RyR2s either through PKA or CaMKII could further contribute to altered RyR2 function rendering them more responsive to luminal Ca 2+ .
14,16
Role of post-translational modification of RyR2 by phosphorylation and thiol oxidation
Altered RyR2 function in HF has been attributed to either hyperphosphorylation 14, 16 or oxidation. 17 The present study shows that both forms of post-translational modifications of RyR2 can be involved at different stages of HF: early and persistent CaMKII-mediated phosphorylation was followed by oxidation of thiols at later stages of HF ( Figure 6 ). In agreement with these results, we recently showed using the same model that abnormal myocyte Ca 2+ handling in latestage HF is normalized by antioxidants. 17 Future experiments will have to define the exact relationships between these two mechanisms during HF development.
Conclusions
We found that during long-term HF, a progressive loss of the ability of RyR2 activity to become refractory gives rise to an increase in arrhythmogenic potential and deterioration of systolic SR Ca 2+ release and contractility in cardiac myocytes. These pathological changes in myocyte Ca 2+ handling were linked to sequential modification of RyR2 channels by CaMKII phosphorylation and thiol oxidation. These results provide new insights into abnormal Ca 2+ handling during HF and suggest molecular bases for temporally targeted mechanistically based therapeutic approaches for this disease.
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